MINI FUTURE ZERTIFIKAT LONG - GILEAD SCIENCES Stock

Certificat

DE000TD9QRM9

Market Closed - BOERSE MUENCHEN 03:36:30 2024-05-10 pm EDT
1.01 EUR +13.48% Intraday chart for MINI FUTURE ZERTIFIKAT LONG - GILEAD SCIENCES
Current month+6.32%
1 month-19.20%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-10 1.01 +13.48% 0
24-05-09 0.89 -3.26% 0
24-05-08 0.92 -8.00% 0
24-05-07 1 +7.53% 0
24-05-06 0.93 +4.49% 0

Real-time BOERSE MUENCHEN

Last update May 10, 2024 at 03:36 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
Issuer HSBC
WKN TD9QRM
ISINDE000TD9QRM9
Date issued 2017-06-27
Strike 55.26 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.73
Lowest since issue 0.48

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
65.96 USD
Average target price
82.93 USD
Spread / Average Target
+25.73%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW